BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       


November Archive 2004 - have your press release here?

Cobra increases quality capabilities and further strengthens compliance with the latest EC clinical trials directive

Tigecycline offers new hope in the battle against MRSA

Symphogen Presents Novel SymplexTM Antibody Isolation Technology for First Time at IBC Antibody Engineering Conference

ASINEX AND BIOVITRUM ANNOUNCE 3 YEAR DRUG DISCOVERY COLLABORATION

Cenomed, Inc. Secures License From Medical College Of Georgia To Intellectual Property And Technology For The Treatment Of Human Cognitive Disorders

CAMBRIDGE ANTIBODY TECHNOLOGY (CAT)ANNOUNCES PRELIMINARY RESULTS FOR THE YEAR ENDED 30 SEPTEMBER 2004

ABLYNX APPOINTS EDWIN MOSES AS CHAIRMAN OF THE BOARD OF DIRECTORS

Dow Pharmaceutical Sciences Appoints Sandra Calman, MD as Director of Clinical Research for the Solano Clinical Research Unit

Promising Antegren data ruffles Serono

Liver Cancer: Battle for survival

Morphochem and Probiodrug collaborate in research and development

PowderMed announces first clinical trial results - POSITIVE OUTCOME OF PHASE I DNA INFLUENZA STUDY

Syngene - Major UK University uses ChemiGenius For Important Research on Blood Vessel Injury

Syngene - A Major New Proteomics Software offering the World’s Fastest 2D Gel Analysis

ADHD children not coming to attention of doctors

Borean Pharma granted European Patent for Protein trimerisation Technology

Yamanouchi to Spin Off Formulation Plant

Roche Diagnostics Launches Highly-sensitive Polymerase Chain Reaction System

Pfizer Japan to Bring New OTC Nasal Spray to Market

NephroGenex Receives Seed Funding

Sigma-Aldrich and Procognia Enter Exclusive Partnership for Commercialization of Functional Human Protein Arrays

Eli Lilly Japan Receives Additional Approval for Vancomycin Hydrochloride for Injection

Alfresa Holdings Begins Developing Molecular Marker Determination Reagent

DeveloGen receives R&D Funds for diabetic Complications Project

NIR DIAGNOSTICS RELEASES ADDITIONAL HemoNIRT DATA

IntegraGen obtains European rights for MODY diabetes genetic testing and plans initial testing service for Germany next year

Sigma-Aldrich Introduces the First Antibody-Based Microarray

Eisai Establishes Pharmaceuticals Marketing Subsidiary in India

ProtoCOL at Major Vaccine Manufacturers Makes Testing Flu Vaccines Twenty Times Faster

Double trouble hits Altana respiratory pipeline

POWDERMED APPOINTS ADAM CHRISTIE AS CHIEF BUSINESS OFFICER

Affimed Therapeutics and Biopharma Unit of Syngenta Enter Into Agreement to Co-develop Tandabs

DOW AND UT AUSTIN EXTEND R&D COLLABORATION FOR DRUG SOLUBILIZATION BASED ON ADVANCED PARTICLE ENGINEERING

BMD obtains FDA approval for its celiac disease diagnostic kit

 

BioNewsCast Press Release Service 2003 Archive

BioNewsCast Press Release Service 2002 Archive

 
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.